Overview

Efficacy Study of Cardizem in Pulmonary Arterial Hypertension

Status:
Withdrawn
Trial end date:
2014-09-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if cardizem is effective in the treatment of nitric oxide non-responder pulmonary arterial hypertension.
Phase:
N/A
Details
Lead Sponsor:
University of South Florida
Treatments:
Calcium Channel Blockers
Diltiazem